INIS
kazakhstan
100%
tuberculosis
79%
genetics
75%
patients
71%
risks
49%
genes
48%
populations
42%
data
37%
genotype
35%
humans
30%
drugs
27%
women
26%
mycobacterium tuberculosis
25%
variations
23%
strains
21%
control
21%
diseases
20%
host
20%
cancer
19%
length
17%
mutations
16%
epidemiology
15%
vitamin d
15%
telomeres
15%
levels
14%
death
13%
evaluation
12%
values
11%
heart failure
11%
receptors
10%
testing
10%
metabolism
10%
viruses
10%
reviews
9%
infectious diseases
8%
rna
8%
asia
8%
biological markers
7%
surgery
7%
fever
7%
carcinomas
7%
esophagus
7%
vaccines
7%
devices
7%
homocysteine
7%
collagen
7%
hepatitis
7%
diet
7%
distribution
7%
breasts
7%
angiotensin
7%
enzymes
7%
cardiovascular diseases
7%
chromosomes
7%
cytology
7%
liver cirrhosis
7%
bypasses
7%
resources
7%
assessments
7%
lactobacillus
7%
carboxylesterases
7%
antibiotics
7%
information
6%
screening
6%
nucleotides
6%
people
6%
comparative evaluations
6%
origin
5%
mortality
5%
pcr
5%
cardiovascular system
5%
Keyphrases
Kazakhstan
77%
Tuberculosis
31%
Mycobacterium Tuberculosis (M. tb)
28%
Whole Genome Sequencing
25%
Pulmonary Tuberculosis
22%
Polymorphism
18%
Tuberculosis Epidemiology
16%
Kazakh
15%
Telomere Length
15%
Whole Genome
14%
Genotype
12%
Central Asia
10%
Genetic Profile
10%
Genomic Variants
10%
Metabolism
9%
Life Expectancy
9%
Genetic Variation
9%
Whole-genome Sequence Data
9%
Host Genetics
8%
Mycobacterium Tuberculosis Strains
8%
Drug Resistance
8%
Genetic Polymorphism
8%
Genetic Variants
8%
High Risk
8%
High-risk Human Papillomavirus Infection
7%
Sequence Variants
7%
Sputum
7%
MIRU-VNTR Genotyping
7%
Patients with Breast Cancer
7%
Kazakh Patients
7%
Draft Genome Sequence
7%
TLR Polymorphism
7%
VDR Polymorphism
7%
SARS-CoV-2 Genome
7%
Salivaomics
7%
Multidrug-resistant Mycobacterium Tuberculosis
7%
Genotype Distribution
7%
Abnormal Cervical Cytology
7%
Body Mass Evolution
7%
Stapleless
7%
Gastric Bypass
7%
Laparoscopic Roux-en-Y Gastric Bypass (LRYGB)
7%
Hypocaloric Diet
7%
XDR-TB
7%
Heart Failure Patients
7%
Vitamin D Pathway
7%
Esophageal Squamous Cell Carcinoma
7%
Haplogroup
7%
Homocysteine Levels
7%
Viral Infection
7%
Genetic Determinants
7%
Innate Immune Response
7%
Omics Technologies
7%
Length Change
7%
Amplicon
7%
COVID-19
7%
Vitamin D Status
7%
Congestive Heart Failure
7%
Olympics
7%
Cardiointervalography
7%
Stress Testing
7%
12-lead
7%
Sequence-based
7%
Randomized Controlled Trial
7%
Bariatric
7%
Variation Analysis
7%
Oxford Nanopore
7%
Metabolic Syndrome
7%
Oxford Nanopore Sequencing
7%
Genomic Analysis
7%
Left Ventricular Assist Device
7%
XDR Strains
7%
Sudden Cardiac Death
7%
Human Papillomavirus Genotypes
7%
Cardiovascular System
7%
Functional Assessment
7%
AutoML
7%
Active Tuberculosis
7%
Risk Prediction
7%
Risk of Progression
7%
Tuberculosis Infection
7%
Direct Oral Anticoagulants
7%
Carboxylesterase 1 (CES1)
7%
Stepfathers
7%
Epidemiological Aspects
7%
Genetic Aspects
7%
Dabigatran
6%
Virus
6%
SNP
5%
High-risk Human Papillomavirus (HR-HPV)
5%
SNP Markers
5%
Cardiovascular Disease
5%
HPV16
5%
Bariatric Surgery
5%
Telomere
5%
Genotype Polymorphism
5%
Multidrug-resistant
5%
MIRU-VNTR
5%
Diabetes
5%
Angiotensin
5%
Biochemistry, Genetics and Molecular Biology
Genotyping
48%
Genetics
40%
Whole Genome Sequencing
32%
Mycobacterium Tuberculosis
26%
Single Nucleotide Polymorphism
20%
Genetic Divergence
17%
Next Generation Sequencing
16%
Drug Resistance
15%
Telomere Length
15%
Ventricular Tachycardia
15%
Variable Number Tandem Repeat
13%
Prevalence
11%
Single-Nucleotide Polymorphism
11%
Life Expectancy
10%
Genetic Polymorphism
10%
Case-Control Study
9%
Haplogroup
9%
Genetic Variation
7%
Survival Rate
7%
Liquid
7%
Enzyme Polymorphism
7%
Telomere
7%
Angiotensin-Converting Enzyme
7%
SARS Coronavirus
7%
Randomized Controlled Trial
7%
Body Mass
7%
Amplicon
7%
Hepatitis Virus
7%
Homocysteine
7%
Hypovitaminosis D
7%
Lactobacillus casei
7%
Carboxylesterase 1
7%
Y Chromosome
7%
TLR8
6%
Folic Acid
5%
MARCO
5%
Drug Sensitivity
5%
Real-Time Polymerase Chain Reaction
5%
Sudden Cardiac Death
5%
UGT1A6
5%
VKORC1
5%